微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
$Exagen(XGN)$ 8-K - Current report Filed: 2019-09-23 AccNo: 0001193125-19-252366 Size: 232 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Exagen(XGN)$ 424B4 - Prospectus [Rule 424(b)(4)] Filed: 2019-09-20 AccNo: 0001193125-19-250698 Size: 3 MB 网页链接
$Exagen(XGN)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-09-20 AccNo: 0001193125-19-250784 Size: 103 KB 网页链接
$Exagen(XGN)$ EFFECT - Notice of Effectiveness Filed: 2019-09-18 AccNo: 9999999995-19-002124 Size: 1 KB 网页链接
$Exagen(XGN)$ S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)] Filed: 2019-09-18 AccNo: 0001193125-19-248504 Size: 41 KB 网页链接
$Exagen(XGN)$ CERT - Filed: 2019-09-17 AccNo: 0001354457-19-000453 Size: 86 KB 网页链接
$Exagen(XGN)$ 8-A12B - Registration of securities [Section 12(b)] Filed: 2019-09-13 AccNo: 0001193125-19-244881 Size: 14 KB 网页链接
$Exagen(XGN)$ S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933 Filed: 2019-09-09 AccNo: 0001193125-19-240403 Size: 4 MB 网页链接